Vitrolife AB (publ) (ADR)
General ticker "VTRLY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.9B (TTM average)
Vitrolife AB (publ) (ADR) does not follow the US Stock Market performance with the rate: -22.0%.
Estimated limits based on current volatility of 0.0%: low 10.70$, high 10.70$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-07, amount 0.12$ (Y1.12%)
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.60$, 22.77$]
- 2025-12-31 to 2026-12-31 estimated range: [8.13$, 18.34$]
Financial Metrics affecting the VTRLY estimates:
- Positive: with PPE of 55.5 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 21.70 > 18.39
- Negative: Industry earnings per price (median), % of -4.62 <= 0
- Positive: Shareholder equity ratio, % of 78.18 > 64.29
- Positive: -0.02 < Operating cash flow per share per price, % of 3.10
Short-term VTRLY quotes
Long-term VTRLY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SEK3,512.00MM | SEK3,609.00MM | SEK3,233.57MM |
| Operating Expenses | SEK7,101.00MM | SEK2,826.00MM | SEK2,654.53MM |
| Operating Income | SEK-3,589.00MM | SEK783.00MM | SEK579.03MM |
| Non-Operating Income | SEK-123.00MM | SEK-109.00MM | SEK-5,171.82MM |
| Interest Expense | SEK94.00MM | SEK98.00MM | SEK81.78MM |
| R&D Expense | SEK228.00MM | SEK117.00MM | SEK104.34MM |
| Income(Loss) | SEK-3,712.00MM | SEK674.00MM | SEK-4,592.79MM |
| Taxes | SEK139.00MM | SEK160.00MM | SEK119.38MM |
| Net Income(Loss)* | SEK-3,851.00MM | SEK513.00MM | SEK-4,711.23MM |
| Stockholders Equity | SEK12,722.00MM | SEK13,639.00MM | SEK7,894.00MM |
| Inventory | SEK413.00MM | SEK422.00MM | SEK413.00MM |
| Assets | SEK16,329.00MM | SEK17,446.00MM | SEK11,124.00MM |
| Operating Cash Flow | SEK757.00MM | SEK907.00MM | SEK635.00MM |
| Capital expenditure | SEK119.00MM | SEK92.00MM | SEK253.80MM |
| Investing Cash Flow | SEK-124.00MM | SEK-377.00MM | SEK-302.00MM |
| Financing Cash Flow | SEK-300.00MM | SEK-286.00MM | SEK-553.00MM |
| Earnings Per Share** | SEK-28.44 | SEK3.79 | SEK-34.79 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.